Health TrialsbyHealthPanel

Pharynx Cancer

3

Review clinical trials related to Pharynx Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer

The objective of this study is to assess two novel positron emission tomography (PET) radiotracers, \[64Cu\]CM500 and \[68Ga\]CM500, for Positron Emission Tomography-Magnetic Resonance Imaging (PET-MR) and Positron Emission Tomography / Computed Tomography (PET-CT) imaging of solid tumors. These tracers have the potential to detect solid tumors throughout the body and may enable doctors to identify smaller tumors than conventional imaging techniques.

Participants needed: 40
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Lumina Pharmaceuticals IncUpdated: Aug 28, 2026Locations: 3
Eligibility criteria

18 years of age or older; [+7]

Less than 18 years of age; [+15]

Read more
Status: Recruiting

Microbiome in Head and Neck Squamous Cell Carcinoma

This study aims to determine whether dysbiosis actively contributes to HNSCC and if so, the underlying molecular mechanisms.

Participants needed: 60
Trial details
Age: 18-100Biological sex: AllType: ObservationalSponsor: University of Colorado, DenverUpdated: Feb 24, 2026Locations: 1
Eligibility criteria

Subjects equal to or above the age of 18. [+4]

Subjects under the age of 18 or over the age of 100 [+1]

Read more
Status: Recruiting

Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.

Evaluation of the Tolerance and Benefits of Mandibular Advanced Device (MAD) for Snoring and Sleep Apnea in Patients with Oropharyngeal Cancer (OPC): Mixed Design Study.

Participants needed: 35
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Centre hospitalier de l'Université de Montréal (CHUM)Updated: Aug 15, 2024Locations: 1
Eligibility criteria

oropharyngeal cancer diagnosis [+4]

pregnant or breastfeeding woman; [+9]

Read more